5-73123789-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173490.8(TMEM171):c.416A>T(p.Asn139Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00033 in 1,613,136 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N139K) has been classified as Likely benign.
Frequency
Consequence
NM_173490.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM171 | NM_173490.8 | c.416A>T | p.Asn139Ile | missense_variant | 2/4 | ENST00000454765.7 | NP_775761.4 | |
TMEM171 | NM_001161342.3 | c.416A>T | p.Asn139Ile | missense_variant | 2/4 | NP_001154814.1 | ||
TMEM171 | XM_011543156.2 | c.416A>T | p.Asn139Ile | missense_variant | 2/4 | XP_011541458.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM171 | ENST00000454765.7 | c.416A>T | p.Asn139Ile | missense_variant | 2/4 | 1 | NM_173490.8 | ENSP00000415030.2 | ||
TMEM171 | ENST00000287773.5 | c.416A>T | p.Asn139Ile | missense_variant | 2/4 | 5 | ENSP00000287773.5 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152148Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000458 AC: 115AN: 250924Hom.: 0 AF XY: 0.000479 AC XY: 65AN XY: 135596
GnomAD4 exome AF: 0.000327 AC: 477AN: 1460870Hom.: 0 Cov.: 40 AF XY: 0.000354 AC XY: 257AN XY: 726620
GnomAD4 genome AF: 0.000361 AC: 55AN: 152266Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 26AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2021 | The c.416A>T (p.N139I) alteration is located in exon 2 (coding exon 1) of the TMEM171 gene. This alteration results from a A to T substitution at nucleotide position 416, causing the asparagine (N) at amino acid position 139 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at